Ewen Sedman is Head of Strategy and Business Operations in Global Discovery and Early Development at Merck Serono. He brings wide-ranging leadership expertise across the whole R&D value chain.
During Ewen’s 30 years of professional experience he has led key projects and functions from early discovery research to late-stage clinical development in a variety of different therapeutic areas. He was closely involved in development programmes for a number of NMEs now approved in both Europe and the USA. Most recently he was responsible for the successful build up of the Neurodegenerative Disease Research unit at Merck Serono.
Ewen holds a combined honours degree in Physiology and Pharmacology. He spends his life between France and the USA, is an avid supporter of Manchester United, a keen music fan and runner.
Ewen Sedman Senior Vice President, Global Research & Early Development Head Strategy and Business Operations Merck Serono
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.